Global Genomics and Proteomics Analytical Instruments Market 2014-2018

Global Genomics and Proteomics Analytical Instruments Market 2014-2018

Category : Healthcare
Published On : July  2014
Pages : 97



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

About Global Genomics and Proteomics Analytical Instruments 
Genomics is the study of the gene and its functions and proteomics is the study of the structure and functions of proteomes or sets of proteins by using molecular biology and bioinformatics tools and technology. Genomics involves the mapping of genes and DNA sequencing to understand the structure and functions of genomes. A proteome is a complete set of proteins expressed by a genome at a certain time. Proteomics primarily involves the use of molecular biology, biochemistry, and genetics to analyze proteins produced by genes through the translation process. Proteins are the primary component of all cells and are responsible for the various functional characteristics of cells. A defect in the genome or proteome structure or function could result in disorders. Thus, genomics and proteomics technologies play an important role in research, drug discovery, and disease diagnosis, which require the identification and study of the defective genome or proteins. It requires various instruments, reagents, and software for protein isolation, purification, identification, quantification, and analysis of the genome and proteome. There are several analytical instruments used for genomics and proteomics, but the instruments most widely used are chromatography systems, mass spectrometers, Polymerase Chain Reaction systems, and Next-generation Sequencing systems. 
TechNavio's analysts forecast the Global Genomics and Proteomics Analytical Instruments market will grow at a CAGR of 7.83 percent over the period 2013-2018.
Covered in this Report
The Global Genomics and Proteomics Analytical Instruments market can be divided into four segments: Chromatography, Polymerase Chain Reaction, Mass Spectrometry, and Next-generation Sequencing. This report covers the present scenario and the growth prospects of the Global Genomics and Proteomics Analytical Instruments market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of analytical instruments in the above four segments. 
TechNavio's report, the Global Genomics and Proteomics Analytical Instruments Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Genomics and Proteomics Analytical Instruments market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• EMEA        
• APAC
Key Vendors
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc. 
• F. Hoffmann-La Roche Ltd.
• Illumina Inc. 
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
Other Prominent Vendors
 
• Becton Dickinson and Co.
• Bruker Corp.
• GE Healthcare
• Jasco Inc.
• Jeol Ltd.
• Luminex Corp.
• Qiagen NV
• Rigaku Corp.
• Shimadzu Corp.
• Sigma Aldrich Co. LLC
• Spectrolab Systems
• Waters Corp. 

Key Market Driver
• Advances in Genomics and Proteomics Technology
• For a full, detailed list, view our report.
Key Market Challenge
• Lack of Knowledge of Genomics and Proteomics
• For a full, detailed list, view our report.
Key Market Trend
• Focus on Drug Discovery and Disease Diagnosis
• For a full, detailed list, view our report.

Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

 

 



01. Executive Summary

02. List of Abbreviations

03. Scope of the Report


  03.1 Market Overview

  03.2 Product Offerings

04. Market Research Methodology

  04.1 Market Research Process

  04.2 Research Methodology

05. Introduction

06. Market Landscape


  06.1 Market Overview

  06.2 Market Size and Forecast

  06.3 Five Forces Analysis

07. Market Segmentation by Technology

  07.1 Global Chromatography Instruments Market

  07.1.1 Market Size and Forecast

  07.2 Global PCR Instruments Market

  07.2.1 Market Size and Forecast

  07.3 Global Mass Spectrometry Instruments Market

  07.3.1 Market Size and Forecast

  07.4 Global NGS Instruments Market

  07.4.1 Market Size and Forecast

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape


  16.1 Competitive Scenario

  16.1.1 Key News

  16.1.2 Mergers and Acquisitions

  16.2 Vendor Analysis 2013

  16.3 Other Prominent Vendors

17. Key Vendor Analysis

  17.1 Agilent Technologies Inc.

  17.1.1 Key Facts

  17.1.2 Business Overview

  17.1.3 Business Segmentation by Revenue 2013

  17.1.4 Business Segmentation by Revenue 2012 and 2013

  17.1.5 Sales by Geography

  17.1.6 Business Strategy

  17.1.7 Key Information

  17.1.8 SWOT Analysis

  17.1.9 Strengths

  17.1.10 Weaknesses

  17.1.11 Opportunities

  17.1.12 Threats

  17.2 Bio-Rad Laboratories

  17.2.1 Key Facts

  17.2.2 Business Overview

  17.2.3 Business Segmentation by Revenue 2012

  17.2.4 Business Segmentation by Revenue 2012 and 2011

  17.2.5 Geographical Segmentation by Revenue 2012

  17.2.6 Business Strategy

  17.2.7 Recent Developments

  17.2.8 SWOT Analysis

  17.2.9 Strengths

  17.2.10 Weakness

  17.2.11 Opportunities

  17.2.12 Threats

  17.3 F. Hoffmann La Roche Ltd.

  17.3.1 Key Facts

  17.3.2 Business Overview

  17.3.3 Business Segmentation

  17.3.4 Business Segmentation by Revenue 2012 and 2013

  17.3.5 Sales by Geography

  17.3.6 Business Strategy

  17.3.7 Key Information

  17.3.8 SWOT Analysis

  17.3.9 Strengths

  17.3.10 Weaknesses

  17.3.11 Opportunities

  17.3.12 Threats

  17.4 Illumina Inc.

  17.4.1 Key Facts

  17.4.2 Business Overview

  17.4.3 Business Segmentation

  17.4.4 Sales by Geography

  17.4.5 Business Strategy

  17.4.6 Key Information

  17.4.7 SWOT Analysis

  17.4.8 Strengths

  17.4.9 Weaknesses

  17.4.10 Opportunities

  17.4.11 Threats

  17.5 PerkinElmer

  17.5.1 Key Facts

  17.5.2 Business Overview

  17.5.3 Business Segmentation by Revenue 2013

  17.5.4 Business Segmentation by Revenue 2012 and 2013

  17.5.5 Business Strategy

  17.5.6 Key Developments

  17.5.7 SWOT Analysis

  17.5.8 Strengths

  17.5.9 Weaknesses

  17.5.10 Opportunities

  17.5.11 Threats

  17.6 Thermo Fisher Scientific Inc.

  17.6.1 Key Facts

  17.6.2 Business Overview

  17.6.3 Business Segmentation by Revenue

  17.6.4 Product Segmentation by Revenue

  17.6.5 Sales by Geography

  17.6.6 Business Strategy

  17.6.7 Key Information

  17.6.8 SWOT Analysis

  17.6.9 Strengths

  17.6.10 Weaknesses

  17.6.11 Opportunities

  17.6.12 Threats

18. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Genomics and Proteomics Analytical Instruments Market 2013-2018 (US$ million)

Exhibit 3: Global Genomics and Proteomics Analytical Instruments market by Technology

Exhibit 4: Chromatography : Segmentation by Technology

Exhibit 5: Polymerase Chain Reaction: Segmentation by Technology

Exhibit 6: Mass Spectrometry : Segmentation by Technology

Exhibit 7: Global Genomics and Proteomics Analytical Instruments Market: Segmentation by Technology 2013

Exhibit 8: Global Chromatography Instruments Market 2013-2018 (US$ million)

Exhibit 9: Global PCR Instruments Market 2013-2018 (US$ million)

Exhibit 10: Global Mass Spectrometry Instruments Market 2013-2018 (US$ million)

Exhibit 11: Global NGS Instruments Market 2013-2018 (US$ million)

Exhibit 12: Global Genomics and Proteomics Analytical Instruments Market: Segmentation by Geography 2013

Exhibit 13: Agilent Technologies Inc.: Business Segmentation by Revenue 2013

Exhibit 14: Agilent Technologies Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)

Exhibit 15: Agilent Technologies Inc.: Sales by Geography 2013

Exhibit 16: Bio-Rad Laboratories: Business Segmentation by Revenue 2012

Exhibit 17: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2011 (US$ million)

Exhibit 18: Bio-Rad Laboratories: Geographical Segmentation by Revenue 2012

Exhibit 19: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013

Exhibit 20: F. Hoffmann-La Roche Ltd: Business Segmentation by Revenue 2012 and 2013

Exhibit 21: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Pharmaceuticals Division)

Exhibit 22: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Diagnostics Division)

Exhibit 23: Illumina Inc.: Business Segmentation 2013

Exhibit 24: Illumina Inc.: Sales by Geography 2013

Exhibit 25: PerkinElmer: Business Segmentation by Revenue 2013

Exhibit 26: PerkinElmer: Business Segmentation by Revenue 2012 and 2013 (US$ billion)

Exhibit 27: Thermo Fisher Scientific Inc.: Business Segmentation by Revenue 2013

Exhibit 28: Thermo Fisher Scientific Inc.: Product Segmentation by Revenue 2013

Exhibit 29: Thermo Fisher Scientific Inc.: Sales by Geography 2013



"



Enquiry Before Buy